Altman Z-Score

Skillsoft appoints a veteran CLO, but this isn't a routine hire. It's a strategic move to install an architect of transformation for its risky AI future.

Capital Power's 2% dividend hike pleases income investors, but a look beneath the surface reveals high debt and a costly energy transition. Is it resilient?

Radiopharm Theranostics secures crucial funding for its promising oncology pipeline, but a sharp stock drop reveals deep investor concerns about dilution.

Borealis Foods launched its high-protein Chef Woo noodles in Costco, a savvy move to tap the 'Ozempic Effect.' But can one product's promise save a company facing dire financial headwinds?

A Malaysian hotpot chain lands a massive data center deal, but with no tech experience and a plunging stock price, is this a brilliant pivot or a desperate gamble?

TKO's massive $800M share buyback signals supreme confidence, but a closer look at the financials reveals a complex story of growth, debt, and risk.

Ingles Markets' steady dividend is more than a financial report; it's a story of resilience, community commitment, and strategic fortitude after Hurricane Helene.

Triller's audacious acquisition of a SpaceX stake sends its stock soaring, but can this high-stakes bet on a space giant save a company plagued by financial woes?

The home-care provider just restructured over a billion in debt. While the company calls it an optimization, the data reveals a story of survival.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

Soaring healthcare costs, fueled by GLP-1 drugs, have employers trapped. A new report shows why flexible benefits are becoming a critical survival strategy.

New research reveals Indigenous-led projects are not just a social good, but a critical economic engine for Canada's energy transition and resource economy.

As National Outlet Shopping Day returns, it's more than a sale. It's Simon's blueprint for the future of retail and a key test of consumer spending.

Canada's new 'AI for All' strategy bets billions on sovereign compute and closing its adoption gap. Can this ambitious plan build a uniquely Canadian AI future?

Facing dire financial warnings, Cosmos Health plans to sell its own facilities to fund a comeback. Is it a stroke of genius or a desperate final gambit?

Fairplay's new user verification signals a market-wide shift. As India's stringent new rules take hold, compliance is becoming a key strategic asset.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.